Gene-network analysis identifies susceptibility genes related to glycobiology in autism
about
Neuroscience in the era of functional genomics and systems biologyGenetics of autistic disorders: review and clinical implicationsShared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorderCharacterization of the deleted in autism 1 protein family: implications for studying cognitive disorders.Linking genes to diseases: it's all in the data.Differential expression of six genes and correlation with fatness traits in a unique broiler populationSerum glycopattern and Maackia amurensis lectin-II binding glycoproteins in autism spectrum disorderFunctional and cellular characterization of human Retinoic Acid Induced 1 (RAI1) mutations associated with Smith-Magenis SyndromeIdentification of uncommon recurrent Potocki-Lupski syndrome-associated duplications and the distribution of rearrangement types and mechanisms in PTLSMIRA: mutual information-based reporter algorithm for metabolic networksThe impact of the metabotropic glutamate receptor and other gene family interaction networks on autism.Rai1 frees mice from the repression of active wake behaviors by light.DIA1R is an X-linked gene related to Deleted In Autism-1.Rai1 Haploinsufficiency Is Associated with Social Abnormalities in Mice.Heterozygous deletion at the RLN1 locus in a family with testicular germ cell cancer identified by integrating copy number variation data with phenome and interactome information.A co-segregating microduplication of chromosome 15q11.2 pinpoints two risk genes for autism spectrum disorder.Retinoic Acid Induced 1, RAI1: A Dosage Sensitive Gene Related to Neurobehavioral Alterations Including Autistic Behaviorδ ENaC: a novel divergent amiloride-inhibitable sodium channelRAI1 transcription factor activity is impaired in mutants associated with Smith-Magenis Syndrome.Identification of rare causal variants in sequence-based studies: methods and applications to VPS13B, a gene involved in Cohen syndrome and autismA phylogenetic study of SPBP and RAI1: evolutionary conservation of chromatin binding modules.Social Responsiveness Scale-aided analysis of the clinical impact of copy number variations in autismWhole Exome Sequencing Reveals Homozygous Mutations in RAI1, OTOF, and SLC26A4 Genes Associated with Nonsyndromic Hearing Loss in Altaian Families (South Siberia).Scan-statistic approach identifies clusters of rare disease variants in LRP2, a gene linked and associated with autism spectrum disorders, in three datasets.The molecular genetics of autism spectrum disorders: genomic mechanisms, neuroimmunopathology, and clinical implicationsThe maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring.Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds.Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder.Protein signatures of oxidative stress response in a patient specific cell line model for autism.LW-AFC Effects on N-glycan Profile in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.Altered brain gene expression but not steroid biochemistry in a genetic mouse model of neurodevelopmental disorder.Copy number variation in the dosage-sensitive 16p11.2 interval accounts for only a small proportion of autism incidence: a systematic review and meta-analysis.Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research.Genetic risk in autism: new associations and clinical testing.Autism spectrum disorders: the quest for genetic syndromes.SHANK3 haploinsufficiency: a "common" but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders.Biomarkers in autism spectrum disorder: the old and the new.Glutamatergic candidate genes in autism spectrum disorder: an overview.Functional annotation of genes overlapping copy number variants in autistic patients: focus on axon pathfinding.Glycan susceptibility factors in autism spectrum disorders.
P2860
Q22337243-F28FC351-23EE-4CD4-85B1-24788BA66154Q24627520-020770C9-00D0-494C-A1E4-52EF9F9524DAQ24627620-C91B7056-26B0-4C44-AD43-C53010BD35A0Q30399182-DF576269-4854-45E0-A849-421B2F0F597AQ33493193-78BEC949-9BAE-4472-BF02-4F44C4A38FCDQ33632745-EA400BBA-771E-4034-A953-F8061EB05EB9Q33651921-F91B5FDB-C20F-4160-9BF7-D1D0642439FBQ33672377-F872AC48-8F57-4217-A05C-FF39C046BF59Q33708568-96D800B5-3C84-42BB-841B-88B84A6C3436Q33760402-17322D2B-0D30-4209-80D8-D792BC16F770Q33764400-43357A46-D232-404F-812A-8C024CB7CA67Q33779025-E43A59EF-6F8C-458B-A722-488EDFA93093Q33802577-BAA6CD40-F859-48C0-85A1-003D1B90410BQ33836605-1B8A6343-F90D-4112-B6AC-A1E9EB741E28Q33940047-39F2BC2D-0F9C-4F41-8756-820D83FA68B3Q34104731-7F28410F-7D68-4608-86DD-07D6B08F327DQ34188749-BED17FAD-1059-4762-98E5-A5B4054EA631Q34300041-A6843F7E-DBCB-4336-8726-BD71160A9629Q34428231-7B0525BC-A145-4366-986A-DA528648A30DQ34682335-3BE4A010-3CC3-44A4-BAA6-003D7F4FF70FQ35036841-7BDA8EE2-7F20-4949-9255-E1A1CA116BE8Q35549465-04371213-3599-4540-A798-4CAE12223343Q35990963-14E501F2-7C17-4DEE-AF52-77B989A4EC9EQ36017094-482B88BD-C50D-4ED5-BBA5-7CE54A0240F6Q36169407-608B8512-3C3E-4436-AFB4-84C907C1749CQ36664282-D480A680-7EE3-46A3-9E45-1701DFCB02C9Q37113859-0D7B8B8A-F99D-4A9B-A33D-E55A28A97520Q37414540-20324E45-8DC3-4A7C-A62B-014B4AA761B8Q37596896-24A9DA86-2809-4355-8E94-D2E4C3AD7048Q37619203-FE69E3BB-E35C-4DDC-A7E6-7660944CBE99Q37624158-043B7E5E-89B5-42C3-B57E-0815F222A2E9Q37834918-E3343D15-3A48-49CB-9AF3-27F18B2B0780Q37953135-5C1E28B4-4AFF-426A-AAA5-B1905E1D807FQ38088742-B9482C46-0628-48D4-8822-35B108A279A5Q38104700-AAD0B547-C6E1-4AD8-AACE-535DED4EAC10Q38113853-FCC1D3DD-DCCC-4A9A-A322-5F03D8DC830BQ38149740-1518E552-DF8A-46DF-86BF-46182E37FE2FQ38184927-0DAF9845-0138-434C-9797-B0B5431B5D4FQ38504827-D419B03E-B265-4146-A252-6A5E82596381Q38897399-C18934FF-E5D2-4140-A9E6-CAFD08118319
P2860
Gene-network analysis identifies susceptibility genes related to glycobiology in autism
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Gene-network analysis identifies susceptibility genes related to glycobiology in autism
@ast
Gene-network analysis identifies susceptibility genes related to glycobiology in autism
@en
type
label
Gene-network analysis identifies susceptibility genes related to glycobiology in autism
@ast
Gene-network analysis identifies susceptibility genes related to glycobiology in autism
@en
prefLabel
Gene-network analysis identifies susceptibility genes related to glycobiology in autism
@ast
Gene-network analysis identifies susceptibility genes related to glycobiology in autism
@en
P2093
P2860
P50
P1433
P1476
Gene-network analysis identifies susceptibility genes related to glycobiology in autism
@en
P2093
Bert van der Zwaag
Emma van Daalen
Eva H Brilstra
Frits A Beemer
Hans Kristian Ploos van Amstel
Henk A Spierenburg
Hylke M Blauw
J Peter H Burbach
Jacob A S Vorstman
Jacobine E Buizer-Voskamp
P2860
P356
10.1371/JOURNAL.PONE.0005324
P407
P577
2009-05-28T00:00:00Z